Women treated for ovarian cancer caused by an inherited faulty gene have a lower risk of developing breast cancer following that treatment, new research from MFT has revealed.
Researchers are to trial a ground-breaking screening test for pre-eclampsia, a potentially life-threatening condition affecting pregnant women and their unborn babies.
Manchester University NHS Foundation Trust (MFT) has now started a recommendations review on the benefits, limitations and implications of transcutaneous bilirubin (TCB) monitoring devices.
The Academy of Medical Science has elected Professor Bill Newman, Consultant in Genomic Medicine, Manchester Centre for Genomic Medicine, Saint Mary’s Hospital, to its prestigious Fellowship.
Congratulations to two research teams at Manchester University NHS Foundation Trust who were recognised at this year’s Making a Difference Awards 2024, hosted by The University of Manchester.
To celebrate International Day of the Midwife, Research Midwife, Emilie Bailey shares her midwifery research journey and why she is proud to contribute to research that helps make pregnancy safer.
Researchers from Saint Mary’s Hospital, part of MFT, have been awarded an American Association for Cancer Research Award for their pioneering work on Lynch-syndrome associated endometrial cancer.
A simple, safe and accurate test that identifies women with womb cancer from a sample taken from the vagina has been developed by clinician scientists in Manchester.